KMKavita Mehta

Kavita Mehta

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Kavita Mehta has a total of 50 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Clinical and immunological correlates of CXCR4 coreceptor use in people with HIV-1 receiving antiretroviral therapy in the Netherlands: a multicentre cohort study

    by Kavita Mehta, Twan Otten, Victoria Rios-Vazquez, Mareva Delporte, Maxime Verschoore, Evy E Blomme, Casper Rokx, Janneke Stalenhoef, Marvin A H Berrevoets, Jan van Lunzen, et al.

  • Open Access

    Enhanced strand transfer and mismatch extension by HIV-1C reverse transcriptase promote sequence motif duplication

    by Arun Panchapakesan, Aditya Pradeepbhai Joshi, Afzal Amanullah, Neelam Pargain, Kavita Mehta, Manisenthil Shanmugam, Jayendra Singh, Chhavi Saini, Narendra Nala, Udupi A. Ramagopal, et al.

    Genetic diversification of HIV-1 is driven largely by the error-prone activity of reverse transcriptase (RT) and the high frequency of template switching during reverse transcription. A rare consequence of nonhomologous recombination is sequence motif duplication, which can alter viral gene regulation and protein function. Previous studies have shown that such duplications occur at higher frequencies in HIV-1C, particularly within the long terminal repeat and p6-Gag regions, where they can confer replication advantages. However, the mechanistic basis for this subtype-specific bias has remained unclear. Here, we investigated whether intrinsic biochemical properties of HIV-1C RT contribute to its elevated duplication frequency. Bioinformatic analysis of 6,877 full-length HIV-1 genomes identified four duplication hotspots across the viral genome, with the highest frequencies in HIV-1C. Comparative sequence analysis revealed several subtype-specific residues in RT, including a conserved threonine at position 359 (T359) in the connection domain. Structural modeling suggested that T359 can form an additional hydrogen bond with the nascent cDNA, potentially stabilizing the RT–template complex. Biochemical characterization of recombinant RT variants demonstrated that residue 359 modulates polymerase activity and maintains subtype-specific optimal catalytic function. Functional assays further showed that HIV-1C RT exhibits enhanced template strand transfer compared with HIV-1B RT. In addition, next-generation sequencing–based primer extension assays revealed that HIV-1C RT extends mismatched 3′ termini more efficiently across multiple mismatch types. Together, these findings indicate that subtype-specific biochemical properties of HIV-1C RT, mediated in part by T359, promote nonhomologous recombination events that generate sequence motif duplications. IMPORTANCE: High-frequency sequence motif duplications are a distinctive feature of HIV-1C, yet the molecular mechanisms underlying their higher prevalence have remained unclear. Here, we demonstrate that intrinsic biochemical properties of HIV-1C reverse transcriptase (RT) promote these events through enhanced template strand transfer and improved extension of mismatched 3′ termini during reverse transcription. These properties increase the probability of nonhomologous recombination events that generate these duplications across the viral genome. Importantly, such duplications have major biological consequences at hotspots. In the long terminal repeat, duplication of transcription factor binding motifs produces promoter variants that alter transcriptional strength, influencing both latency establishment and reversal. In the p6-Gag region, duplication of the PTAP motif is linked to compensatory adaptation in drug resistance and may enhance viral fitness under antiretroviral pressure. Together, our findings provide a mechanistic explanation for the emergence of clinically relevant viral variants and highlight how subtle subtype-specific RT polymorphisms can shape HIV-1 evolution and persistence.


  • Open Access

    HIV-1 virome profiling using HIV-PULSE to guide therapeutic and curative interventions

    by Sofie De Braekeleer, Laurens Lambrechts, Liesbet Termote, Mareva Delporte, Kavita Mehta, Vasiliki Matzaraki, Evy E. Blomme, Philippe Lemey, Bram Vrancken, Casper Rokx, et al.

  • Open Access

    Enhanced strand transfer and mismatch extension by HIV-1C reverse transcriptase promote sequence motif duplication

    by Arun Panchapakesan, Aditya Pradeepbhai Joshi, Afzal Amanullah, Neelam Pargain, Kavita Mehta, Manisenthil Shanmugam, Jayendra Singh, Chhavi Saini, Narendra Nala, Udupi A Ramagopal, et al.

    Genetic diversification of HIV-1 is driven largely by the error-prone activity of reverse transcriptase (RT) and frequent template switching during reverse transcription. A rare outcome of nonhomologous recombination is sequence motif duplication, which can alter viral gene regulation and protein function. Previous studies have shown that such duplications occur at significantly higher frequencies in HIV-1 subtype C (HIV-1C), particularly within the long terminal repeat (LTR) and p6-Gag regions, where they can confer replication advantages. However, the mechanistic basis for this subtype-specific bias remains unclear. We therefore investigated whether intrinsic biochemical properties of HIV-1C RT contribute to its elevated duplication frequency. Bioinformatic analysis of 6,877 full-length HIV-1 genomes identified four duplication hotspots, with the highest frequencies in HIV-1C. Comparative sequence analysis of RT revealed several subtype-specific residues, including a highly conserved threonine at position 359 (T359) in the connection domain of HIV-1C RT. Structural modeling suggested that T359 can form an additional hydrogen bond with the nascent cDNA, potentially stabilizing the RT-template complex. Biochemical characterization of recombinant RT variants demonstrated that residue 359 modulates polymerase activity and maintains subtype-specific optimal catalytic function. Functional assays further revealed that HIV-1C RT exhibits enhanced template strand transfer compared with HIV-1B RT. In addition, next-generation sequencing-based primer extension assays showed that HIV-1C RT extends mismatched 3′ termini more efficiently across multiple mismatch types. Together, these findings indicate that subtype-specific biochemical properties of HIV-1C RT, particularly enhanced strand transfer and mismatch extension mediated in part by T359, promote nonhomologous recombination events that generate sequence motif duplications. This work provides a mechanistic explanation for the elevated duplication frequency characteristic of HIV-1C and highlights how subtle RT polymorphisms can shape viral evolutionary trajectories.

  • Open Access

    Longitudinal plasma proteomic signatures of elite and viremic spontaneous HIV controllers

    by Nadira Vadaq, Albert L. Groenendijk, Jéssica C. dos Santos, Kavita Mehta, Ferdinand W.N.M. Wit, Wilhelm A. J. W. Vos, Martinus J. T. Blaauw, Louise E. van Eekeren, Laurens Lambrechts, Sofie Rutsaert, et al.

    A small percentage of people living with HIV (PLHIV) spontaneously regulate viral replication without suppressive antiretroviral treatment (ART) and are categorized into ‘elite controllers’ (EC, HIV-RNA < 50 c/mL) and ‘viremic controllers’ (VC, HIV-RNA between 50-10,000 c/ml). Some EC and VC may lose controller status in time. Here we provide extensive plasma proteomics to identify biomarkers and pathways related to spontaneous viral control and its long-term preservation among 36 EC and 147 VC (discovery) and 14 EC and 5 VC (validation). VC exhibited higher concentrations of CRTAM, LY9, and CD6 and lower concentrations of VAT1 compared to EC in both the discovery and validation cohort. Longitudinal analysis of pre- and post-ART samples (median follow-up: 5.3 years) revealed downregulation of various immune-related proteins in both EC and VC. Over a 17-year follow-up period, loss of viral control occurred in 31% of VC and 3% of EC. T-cell associated proteins (CRTAM, LY9, CD6), along with ICAM3, SH2D1A, C1QL2, and CNGB3, predicted loss of viral control years before its occurrence. Markers of chronic immune activation (sPD-L1, sCD25, IL-10, TGF-β, IFN-γ, and TNF-α) and systemic inflammation (TNF, IL-1β, IL-6, and sCD14) were not predictive. Our findings underscore the dynamic interplay between T cell function and viral replication in maintaining HIV control and identify key biomarkers that predict viral load surges.